Related Experiment Videos
[Solid malignant neoplasms in the first year of life]
R Gómez-Martínez1, N Silva-Padilla, B Torres-Sauza
1Servicio de Oncología Pediátrica, Unidad Médica de Alta Especialidad, Hospital de Pediatría, Centro Médico Nacional de Occidente, Instituto Mexicano del Seguro Social, CP 44340 Guadalajara, Jalisco, México. ricardo_gomezmartinez@yahoo.com.mx
Anales De Pediatria (Barcelona, Spain : 2003)
|June 2, 2005
Summary
Pediatric solid malignant tumors are rare, often diagnosed late. Early detection and multicenter studies are crucial for improving survival rates in infants with childhood cancers.
Area of Science:
- Pediatric Oncology
- Oncology
- Cancer Research
Context:
- Solid malignant tumors in infants are rare but significant causes of mortality in Mexico.
- Limited data exists on the characteristics of these pediatric cancer cases.
- This study details single-institution experience with infant solid tumors.
Purpose:
- To describe the clinical characteristics, treatment, and outcomes of infants diagnosed with solid malignant tumors.
- To highlight the challenges in early detection and management of rare childhood cancers.
Summary:
- Analyzed 45 infants with solid tumors; common types included neuroblastoma (31%), nephroblastoma (13%), and retinoblastoma (13%).
- Most patients presented with advanced-stage disease, necessitating aggressive treatment including surgery (55%) and chemotherapy (80%).
- Overall survival reached 81% at 66 months, despite 24% experiencing treatment complications.
Impact:
- Emphasizes the need for increased pediatrician awareness to improve early diagnosis of infant cancers.
- Suggests multicenter studies are essential for developing optimized treatment protocols and enhancing patient prognosis and quality of life.